Treatment of Benign Prostatic Hyperplasia by Natural Drugs

被引:71
作者
Csikos, Eszter [1 ]
Horvath, Adrienn [2 ]
Acs, Kamilla [1 ]
Papp, Nora [1 ]
Balazs, Viktoria Lilla [1 ]
Dolenc, Marija Sollner [3 ]
Kenda, Masa [3 ]
Kocevar Glavac, Nina [4 ]
Nagy, Milan [5 ]
Protti, Michele [6 ]
Mercolini, Laura [6 ]
Horvath, Gyorgyi [1 ]
Farkas, Agnes [1 ]
机构
[1] Univ Pecs, Dept Pharmacognosy, Fac Pharm, H-7624 Pecs, Hungary
[2] Univ Pecs, Dept Pharmaceut Biol, Fac Pharm, H-7624 Pecs, Hungary
[3] Univ Ljubljana, Dept Pharmaceut Chem, Fac Pharm, SI-1000 Ljubljana, Slovenia
[4] Univ Ljubljana, Dept Pharmaceut Biol, Fac Pharm, SI-1000 Ljubljana, Slovenia
[5] Comenius Univ, Dept Pharmacognosy & Bot, Fac Pharm, SK-83232 Bratislava, Slovakia
[6] Univ Bologna, Alma Mater Studiorum, Res Grp Pharmaco Toxicol Anal PTA Lab, Dept Pharm & Biotechnol FaBiT, I-40126 Bologna, Italy
关键词
benign prostatic hyperplasia; medicinal plants; phytotherapy; saw palmetto; preclinical studies; clinical efficacy; safety issues; URINARY-TRACT SYMPTOMS; PYGEUM-AFRICANUM EXTRACT; PUMPKIN SEED OIL; ROYSTONEA-REGIA FRUITS; NETTLE URTICA-DIOICA; CERNITIN POLLEN EXTRACT; PHYTO-ESTROGENIC ACTION; URETHRAL SMOOTH-MUSCLE; MARITIME PINE BARK; DOUBLE-BLIND;
D O I
10.3390/molecules26237141
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Benign prostatic hyperplasia (BPH) is one of the most common urinary diseases affecting men, generally after the age of 50. The prevalence of this multifactorial disease increases with age. With aging, the plasma level of testosterone decreases, as well as the testosterone/estrogen ratio, resulting in increased estrogen activity, which may facilitate the hyperplasia of the prostate cells. Another theory focuses on dihydrotestosterone (DHT) and the activity of the enzyme 5 alpha-reductase, which converts testosterone to DHT. In older men, the activity of this enzyme increases, leading to a decreased testosterone/DHT ratio. DHT may promote prostate cell growth, resulting in hyperplasia. Some medicinal plants and their compounds act by modulating this enzyme, and have the above-mentioned targets. This review focuses on herbal drugs that are most widely used in the treatment of BPH, including pumpkin seed, willow herb, tomato, maritime pine bark, Pygeum africanum bark, rye pollen, saw palmetto fruit, and nettle root, highlighting the latest results of preclinical and clinical studies, as well as safety issues. In addition, the pharmaceutical care and other therapeutic options of BPH, including pharmacotherapy and surgical options, are discussed, summarizing and comparing the advantages and disadvantages of each therapy.
引用
收藏
页数:32
相关论文
共 242 条
[1]   Medicinal plants used in traditional medicine by Oromo people, Ghimbi District, Southwest Ethiopia [J].
Abera, Balcha .
JOURNAL OF ETHNOBIOLOGY AND ETHNOMEDICINE, 2014, 10
[2]   Ameliorative effect of pumpkin seed oil against emamectin induced toxicity in mice [J].
Abou-Zeid, Shimaa M. ;
AbuBakr, Huda O. ;
Mohamed, Mostafa A. ;
El-Bahrawy, Amanallah .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 98 :242-251
[3]   Protective effect of Pumpkin seed extract on sperm characteristics, biochemical parameters and epididymal histology in adult male rats treated with Cyclophosphamide [J].
Aghaei, S. ;
Nikzad, H. ;
Taghizadeh, M. ;
Tameh, A. A. ;
Taherian, A. ;
Moravveji, A. .
ANDROLOGIA, 2014, 46 (08) :927-935
[4]   Pre-roasting treatments significantly impact thermal and kinetic characteristics of pumpkin seed oil [J].
Aktas, Nesimi ;
Uzlasir, Turka ;
Tuncil, Yunus Emre .
THERMOCHIMICA ACTA, 2018, 669 :109-115
[5]   RETRACTED: Attenuation of Benign Prostatic Hyperplasia by Optimized Tadalafil Loaded Pumpkin Seed Oil-Based Self Nanoemulsion: In Vitro and In Vivo Evaluation (Retracted Article) [J].
Alhakamy, Nabil A. ;
Fahmy, Usama A. ;
Ahmed, Osama A. A. .
PHARMACEUTICS, 2019, 11 (12)
[6]   What do we know about phytotherapy of benign prostatic hyperplasia? [J].
Allkanjari, Olta ;
Vitalone, Annabella .
LIFE SCIENCES, 2015, 126 :42-56
[7]  
American Urological Association, 2010, GUID MAN BEN PROST H
[8]   The progression of benign prostatic hyperplasia: Examining the evidence and determining the risk [J].
Anderson, JB ;
Roehrborn, CG ;
Schalken, JA ;
Emberton, M .
EUROPEAN UROLOGY, 2001, 39 (04) :390-398
[9]   PYGEUM-AFRICANUM EXTRACT FOR THE TREATMENT OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA - A REVIEW OF 25 YEARS OF PUBLISHED EXPERIENCE [J].
ANDRO, MC ;
RIFFAUD, JP .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (08) :796-817
[10]  
[Anonymous], 2016, IEEE-ASME T MECH, DOI DOI 10.1017/S0007123415000642